About Harvard Bioscience
Harvard Bioscience is a company based in Holliston (United States) founded in 1901. The company has 355 employees. Harvard Bioscience has completed 9 acquisitions, including AHN Biotechnologie, DSI and Denville Scientific. Harvard Bioscience offers products and services including Spectrophotometers and Patch Clamp Amplifiers.
- Headquarter Holliston, United States
- Employees 355
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website harvardbioscience.com
- Social LinkedIn X YouTube
- Legal Name Harvard Bioscience, Inc.
- Annual Revenue$86.55 M (USD)-8.06as on Dec 31, 2025
- Net Profit-$56.7 M (USD)-357.07as on Dec 31, 2025
- EBITDA$6.04 M (USD)149.28as on Dec 31, 2025
- Latest Funding Round$783.32K (USD), Grant
Apr 2009
- InvestorsHHS
& 1 more
- Employee Count355
- Investments & AcquisitionsAHN Biotechnologie
& 8 more
Products & Services of Harvard Bioscience
Harvard Bioscience offers a comprehensive portfolio of products and services, including Spectrophotometers and Patch Clamp Amplifiers.
Spectrophotometers are utilized for measuring optical properties in research and production settings.
These amplifiers are employed for recording electrical activities in cells during scientific studies.
Apps and channels of Harvard Bioscience
its YouTube channel Harvard Bioscience has 390 subscribers and 30 videos.
Videos from Harvard Bioscience
The most watched videos on Harvard Bioscience's YouTube channel, Harvard Bioscience (390 subscribers). Click a video to play it here.
More on Harvard Bioscience.
Funding Insights of Harvard Bioscience
- Total Rounds 5
- Last Round Grant — $783,321
- First Round $492,000
(May 2001)
- Investors Count 2
All 5 funding rounds of Harvard Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2009 | $783,321 | Grant | – | – | |
| Apr 2009 | $783,321 | Grant | – | – | |
| Aug 2008 | $1.29M | Grant | – | – | |
| Apr 2003 | $1.29M | Grant | – | – | |
| May 2001 | $492,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Harvard Bioscience
Harvard Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Harvard Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Harvard Bioscience
11 people are tracked at Harvard Bioscience (5 in leadership, 4 in board & advisors, 2 in team); the tracked headcount is 355.
| Name | Role | Group |
|---|---|---|
Nitya Shetty | VP, Global Research & Development | Leadership |
Lori Packer | VP, Global People Operations | Leadership |
John Fry | Chief Legal Counsel & Corporation Secretary | Leadership |
James Green | Chairman, President & CEO | Leadership |
Jennifer Cote | Chief Financial Officer & Treasurer | Leadership |
Bertrand Loy | Director | Board & advisors |
Katherine A. Eade | Director | Board & advisors |
Alan Edrick | Director | Board & advisors |
Thomas W. Loewald | Director | Board & advisors |
Ryan Wallace | SVP, Global Sales | Team |
David Balcom | SVP, Operations | Team |
Complete people profiles for Harvard Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Harvard Bioscience
Harvard Bioscience is a publicly listed company on the NASDAQ with ticker symbol HBIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Dec 2000
- Listed onNASDAQ: HBIO
- Listed entityHarvard Bioscience, Inc.
- Exchange sectorHealth technology
- ISINUS4169062043
- Share price$8.24 (+1.35% on the day) · 2026-10-09
- Market capitalisation$37.5M
- EPS (diluted, trailing year)$-2.32
- Volume (last session)12,404
Financials of Harvard Bioscience
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $86.5M | -$56.7M | $6.0M |
| 2024 | $94.1M | -$12.4M | $2.4M |
| 2023 | $112.2M | -$3.4M | $9.3M |
| 2022 | $113.3M | -$9.5M | $2.8M |
| 2021 | $118.9M | -$288,000 | $11.0M |
Detailed financial statements for Harvard Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Harvard Bioscience
Harvard Bioscience has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include AHN Biotechnologie, DSI and Denville Scientific.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DSI is engaged in providing preclinical research solutions and devices. | datasci.com | St. Paul, Canada | 1984 | Jan 2018 | $70M | |
Patch clamp systems for electrophysiology research are manufactured. | heka.com | Morsbach, Germany | 1996 | Jan 2015 | •••• | |
Tools and systems for electrophysiology are developed and supplied. | multichannelsystems.com | Reutlingen, Germany | 1996 | Jun 2014 | •••• | |
Develops and markets liquid handling products | ahn-bio.de | Nordhausen, Germany | 1999 | Jun 2012 | •••• | |
Molecular biology products and lab consumables are distributed for research. | denvillescientific.com | Holliston, United States | 1979 | Sep 2009 | •••• | |
Online pharmacy store | genemachines.com | San Carlos, United States | 1997 | Mar 2003 | $8.1M | |
Genomic and proteomic instruments plus reagents are manufactured. | genomicsolutions.com | Ann Arbor, United States | 1997 | Jul 2002 | $9M | |
High-throughput systems for screening and sorting large particles are provided. | unionbio.com | Holliston, United States | 1998 | May 2001 | $17.5M | |
Laboratory instruments are manufactured for electrophysiological and cellular sciences. | warneronline.com | Hamden, United States | 1989 | May 2001 | •••• |
Complete acquisition details for Harvard Bioscience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Harvard Bioscience
13 dated milestones of Harvard Bioscience across 117 years, from founding to its latest funding, stage changes and deals.
- Founded Harvard Bioscience is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Warner Instruments.
- Funding First funding round of $492K.
- Acquisition Acquires Union Biometrica.
- Acquisition Acquires Genomic Solutions.
- Acquisition Acquires GeneMachines.
- Funding Latest funding round, Grant, of $783K.
- Acquisition Acquires Denville Scientific.
- Acquisition Acquires AHN Biotechnologie.
- Acquisition Acquires Multi Channel Systems.
- Acquisition Acquires HEKA Elektronik.
- Acquisition Acquires DSI.
Web traffic of Harvard Bioscience
The website of Harvard Bioscience (harvardbioscience.com) receives about 16.1K visits a month and ranks #1,976,600 among all websites worldwide, #2,685 in Biotechnology and Pharmaceuticals.
- Monthly visits16.1K
▲ 37% vs previous month
- Unique visitors5.3K
per month
- Global rank#1,976,600
among all websites
- Category rank#2,685
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.8
- Average visit35 sec
- DevicesDesktop 37% · Mobile 63%
Latest news on Harvard Bioscience
Complete news archive for Harvard Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Harvard Bioscience
10 companies that operate in the same segment as Harvard Bioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Harvard Bioscience
Harvard Bioscience was founded in 1901 and raised its 1st funding round 100 years after it was founded.
Harvard Bioscience is headquartered in Holliston, United States. It is registered at Holliston, Massachusetts, United States.
Harvard Bioscience has 355 employees.
Annual revenue of Harvard Bioscience is $86.55M as on Dec 31, 2025.
Provider of life science equipment and instruments. This company manufactures and supplies a wide array of tools for research and production in the life sciences sector. Their offerings include spectrophotometers, cell density meters, patch clamp amplifiers, electroporation systems, and implantable telemetry devices. The company also provides services such as IQOQ field services. Their product portfolio caters to academic research institutions, contract research organizations, and pharmaceutical and biotech companies involved in the discovery, production, and safety testing of therapeutics.
Harvard Bioscience offers Spectrophotometers and Patch Clamp Amplifiers.
Yes, Harvard Bioscience is publicly traded on NASDAQ under the ticker symbol HBIO.
Harvard Bioscience has made 9 acquisitions, including AHN Biotechnologie, DSI, and Denville Scientific.
Harvard Bioscience has 2 investors. Key investors include HHS, and National Science Foundation.
Harvard Bioscience operates through Harvard Bioscience, Inc.